(Q79360278)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Free interferon-alpha/beta receptors in the circulation of patients with adenocarcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

author name string

Julian L Ambrus

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Wlodzimierz Dembinski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Julian L Ambrus

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Donald E Sykes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Selina Akhter

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Mahmoud N Kulaylat

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Abul Islam

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Kailash C Chadha

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 December 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

2730-2733

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669296%20AND%20SRC:MED&resulttype=core&format=json

Cytokine therapeutics: lessons from interferon alpha

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11843

7 January 2021

Introduction: interferon's connection to cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11843

7 January 2021

Why do so many cancer patients fail to respond to interferon therapy?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11843

7 January 2021

Interferon and interferon inhibitor levels in patients infected with varicella-zoster virus, acquired immunodeficiency syndrome, acquired immunodeficiency syndrome-related complex, or Kaposi's sarcoma, and in normal individuals

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11843

7 January 2021

Interferon inactivator(s) in patients with AIDS and AIDS-unrelated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11843

7 January 2021

Interferon inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11843

7 January 2021

The interferon system in carcinoma of the cervix. Effect of radiation and chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11843

7 January 2021

Variations of interferon inactivators and/or inhibitors in human serum and their relationship to interferon therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11843

7 January 2021

An inhibitor of interferon action: II. Biological properties of the IFN-gamma-associated inhibitor of interferon action

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11843

7 January 2021

Soluble interferon-alpha receptor molecules are present in body fluids

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11843

7 January 2021

Purification of soluble cytokine receptors from normal human urine by ligand-affinity and immunoaffinity chromatography

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11843

7 January 2021

Soluble cytokine receptors are present in normal human urine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11843

7 January 2021

The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11843

7 January 2021

Poxvirus-encoded soluble cytokine receptors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11843

7 January 2021

The Ebola virus VP35 protein functions as a type I IFN antagonist.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11843

7 January 2021

Identifiers

DOI

10.1002/CNCR.11843

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14669296%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference